ArticleFrontiers in oncology2026

Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study.

Giulia Pasello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.